CUE icon

Cue Biopharma

49 hedge funds and large institutions have $10.4M invested in Cue Biopharma in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
-6
Holders Change %
-10.91%
% of All Funds
0.67%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
8
Reduced
13
Closed
13
Calls
$20K
Puts
$6K
Net Calls
+$14K
Net Calls Change
-$25K
Name Holding Trade Value Shares
Change
Shares
Change %
Millennium Management
51
Millennium Management
New York
-$75.5K -69,295 Closed
Jane Street
52
Jane Street
New York
-$69.5K -63,767 Closed
HF
53
HRT Financial
New York
-$53K -49,055 Closed
PAS
54
Point72 Asia (Singapore)
Singapore
-$30.3K -27,764 Closed
VF
55
Virtu Financial
New York
-$18K -16,829 Closed
Susquehanna International Group
56
Susquehanna International Group
Pennsylvania
-$14.5K -13,258 Closed
CSS
57
Cubist Systematic Strategies
Connecticut
-$3.99K -3,661 Closed
LFG
58
Larson Financial Group
Missouri
-$1.53K -1,400 Closed
Fidelity Investments
59
Fidelity Investments
Massachusetts
-$105 -96 Closed
PD
60
Point72 (DIFC)
United Arab Emirates
-$72 -66 Closed
Citigroup
61
Citigroup
New York
-$47 -43 Closed
SS
62
SBI Securities
Japan
-$1 -1 Closed